

University of Michigan scientists discovered a breakthrough treatment combination that stops prostate cancer cells from escaping hormone therapy by changing their identity.

The two-drug approach slowed tumor growth significantly in lab studies and could transform treatment for thousands of men facing aggressive, treatment-resistant disease.

Want to know more?